Stock RAC RACE ONCOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Race Oncology Limited

Equities

RAC

AU000000RAC3

Market Closed - Australian S.E.
Other stock markets
 07:10:13 28/06/2024 BST 		5-day change 1st Jan Change
1.825 AUD +1.11% Intraday chart for Race Oncology Limited -0.82% +117.26%
06-26 Race Oncology Concludes GLP Non-clinical Toxicology and Safety Pharmacology Studies for RC220 Bisantrene; Shares Jump 10% MT
06-20 Race Oncology Appoints George Clinical for RC220 Bisantrene Phase 1 Trial MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Race Oncology Appoints George Clinical for RC220 Bisantrene Phase 1 Trial
Race Oncology Receives US FDA Rare Pediatric Disease Designation for Leukemia Medication
Race Oncology Validates Efficacy of Blood Cancer Therapy in Animal Study; Shares Rise 6%
Race Oncology Secures US FDA Orphan Drug Designation for Leukemia Medication; Shares Rise 5%
Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6%
Race Oncology Says Study Shows Lead Asset's Efficacy in Blood Cancer Treatment
Race Oncology Widens Loss in Fiscal H1
Race Oncology Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Race Oncology Names CEO; Shares Jump 5%
Race Oncology Limited Appoints Daniel Tillett as Chief Executive Officer
Race Oncology Initiates Toxicology, Safety Pharmacology Studies of Chemotherapy Drug
Race Oncology Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Race Oncology Limited Announces Board Changes
Race Oncology Secures More R&D Tax Rebate for Fiscal Year 2022; Shares Rise 4%
Race Executes Agreement with Ardena for GMP Manufacturing of RC220
Race Oncology Signs Manufacturing Deal for Intravenous Formulation; Shares Fall 4%
Race Oncology Limited Executes Global License Agreement with City of Hope to Access FTO IP
Race Oncology Limited Announces Board Changes
Race Oncology Names Chief Medical Officer
Race Oncology Limited Appoints Michelle Rashford Chief Medical Officer, Effective 1 July 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RAC Stock
  4. News Race Oncology Limited
  5. Other languages